Webinar

Mr WCEA Administrator
  • Duration: 15m

  • Ref. 197407

Course Description* Please add a course description with a minimum of 20 characters.

2020 In Review: Landmark Hematology and Oncology Drug Approvals - TECHNICIAN

Bradi L. Frei, PharmD, MSc, BCOP, BCPS & Laura Roccograndi, PharmD
  • Duration: 1h

  • Ref. 197120

This one-hour webinar will review the new medications approved in 2020 for hematology and oncology treatments. Review landmark trial data and use case-based scenarios to evaluate the new drugs and efficacy in treatment use.

Let's Play! Learning through play for individuals with autism

Anderson Center Consulting
  • Duration: 1h

  • Ref. 197515

This training is designed to provide parents/caregivers with the basic framework for how play develops throughout childhood and how that may present differently for individuals with autism. Discussion of several practical strategies and tips for supporting play development in simple ways are provided throughout the training. Par....

2021 Leader Training: New Leader Essentials: Presidents and Vice Presidents

Diane Pokluda, Yvette Milner & Betty Plunkett
  • Duration: 1h

  • Ref. 197188

Are you a newly elected president or vice president? Have you been in this role for less than five years? Curious about what comes next? This session, geared toward newer officers, provides some answers to those questions. You’ll receive tips and advice about how to best perform your duties, whom to turn to for help, and where t....

Podiatry Management of Laminitis

Dr. Craig Lesser
  • Duration: 1h

  • Ref. 197604

Discussion of practical and case based approaches to treatment of the laminitic horse.

TEST 01

Mr WCEA Administrator
  • Ref. 197626

0.25 Hours

https://www.youtube.com/watch?v=7qfNrtm5Mbg

Navigating the Neurotrophic Keratitis Treatment Landscape: Integrating Innovation and Individualized Care

Marjan Farid, Francis S Mah, Bruce I Gaynes, Kristi Kay Orbaugh, Brad Boyette
  • Duration: 30m

  • Ref. 201324

0.5 Hours

Neurotrophic keratitis (NK) is a rare, progressive corneal disorder that can cause partial or complete vision loss and significantly impact quality of life. Traditionally, treatments have focused on symptom management, but with the approval of a targeted therapy and ongoing research into additional treatments, options now exist....

The Silent Sense: Expert Strategies for Recognizing and Diagnosing Neurotrophic Keratitis

Marjan Farid, Francis S Mah, Bruce I Gaynes, Kristi Kay Orbaugh, Brad Boyette
  • Duration: 30m

  • Ref. 201328

0.5 Hours

Neurotrophic keratitis (NK) is a rare, degenerative corneal disease characterized by reduced or absent corneal sensation. Its rarity, potential asymptomatic progression, and nonspecific presentation often cause diagnostic delays. Prompt, appropriate treatment is crucial to prevent irreversible corneal damage. In this first vi....

Examining Cervical Cancer: Guideline-Concordant Screening and Referral Practices

Linda R. Duska, Melissa A. Simon, Abimbola Farinde, Jason Welch, Annette Sophin
  • Duration: 30m

  • Ref. 201343

0.5 Hours

With the frequent changes in cervical cancer screening guidelines in recent years, coupled with widening disparities among vulnerable and high-risk populations, it's more important than ever to stay up to date on current screening guidelines to diagnose cervical cancer early and improve equitable care for vulnerable and high-ris....

HIV Prevention for Black Women: Overcoming Barriers and Enhancing Access

Oni J Blackstock, Jewel Sawyer, Ricardo Correa, Abimbola Farinde, Joyce M Knestrick
  • Duration: 1h

  • Ref. 201341

1 Hours

Despite advancements in HIV prevention, Black women continue to be disproportionately impacted by HIV and face barriers to accessing pre-exposure prophylaxis (PrEP). To address this urgent need, clinicians must be equipped with the knowledge and strategies to elevate awareness and ensure equitable access to HIV prevention and se....

Novel and Emerging Evidence in Early-Stage Breast Cancer

Erika P. Hamilton, Jane Lowe Meisel, Douglas S Burgoyne, Mark A Rubin, Annette Sophin, Michele B Kaufman
  • Duration: 1h

  • Ref. 201360

1 Hours

Novel and emerging therapies are enabling a more individualized approach to care in early-stage breast cancer. As immunotherapy and targeted agents move into earlier lines of treatment, ensure your team is current on evidence-based treatment strategies and updated guideline recommendations. Tune in to Part 1 of 6 of our Breas....

The Evolving Treatment Landscape for Triple-Negative Breast Cancer: New Targeted, Immuno-Oncology, and Emerging Combination Approaches

Aditya Bardia, Sara A Hurvitz, Douglas S Burgoyne, Kelly Valla, Mark A Rubin, Annette Sophin, Joyce M Knestrick
  • Duration: 1h 15m

  • Ref. 201367

1.25 Hours

With the advent of immunotherapy, antibody-drug conjugates, and other targeted therapies, impressive strides have been made to improve historically dismal outcomes among patients with triple-negative breast cancer (TNBC). With additional promising therapeutic strategies on the horizon, it is important to remain up to date with e....

Addressing Persistent Challenges in Treatment and Management of Low-Grade Serous Ovarian Carcinoma to Amplify the Latest Evidence in Emerging Therapies

Kathleen N Moore, David M. Gershenson, Stephanie Joyce, Michele B Kaufman, Ricardo Correa
  • Duration: 1h

  • Ref. 201354

1 Hours

Join us for an exciting on-demand video masterclass designed to revolutionize your approach to ovarian cancer care! Dive into the critical distinctions between low-grade serous ovarian carcinoma (LGSOC) and high-grade serous ovarian carcinoma (HGSOC), and uncover the unique epidemiology, pathophysiology, and disease biology that....

The Emergence of a New Subtype: HER2-Low Breast Cancer

Aditya Bardia, Jane Lowe Meisel, Douglas S Burgoyne, Kelly Valla, Mark A Rubin, Annette Sophin, Joyce M Knestrick
  • Duration: 30m

  • Ref. 201366

0.5 Hours

The current binary classification of positive or negative HER2 status is evolving, and many patients formerly classified as HER2-negative are now considered HER2-low, and may benefit from HER2-targeted therapy. This highlights the importance of accurate biomarker assessment and interpretation to evaluate appropriate treatment op....

Tailoring Multiple Sclerosis Treatments Based on Clinical and Patient-Specific Factors

Joseph R Berger, Aaron E Miller, Ricardo Correa, Michele B Kaufman, Kristi Kay Orbaugh
  • Duration: 30m

  • Ref. 201353

0.5 Hours

Navigating treatment options for multiple sclerosis (MS) is a challenging task that is further compounded by individualizing treatment based on the latest clinical evidence as well as patient specific factors. In this 30-minute video, an MS expert will review patient-centered strategies in treatment decision-making and their....

Navigating the Complexities of PH-ILD Diagnosis and Treatment: Implications for Managed Care Professionals

Steven D. Nathan, Michael R Stinchon, Abimbola Farinde, Kristi Kay Orbaugh, Mark A Rubin
  • Duration: 30m

  • Ref. 201348

0.5 Hours

Pulmonary hypertension associated with interstitial lung disease (PH-ILD) is a complex condition due to the overlap of two distinct, often progressive, disease courses. The development of PH in ILD impacts symptoms, functional status, economic burden, and mortality rates to a greater degree than ILD alone. Tune in to this mul....

Advancing Lung Cancer Screening: Detection and Management of Early-Stage Lung Cancer

Jacob M. Sands, Michele B Kaufman, Mark A Rubin, Annette Sophin
  • Duration: 1h

  • Ref. 201356

1 Hours

Lung cancer screening with low-dose computed tomography (CT) scanning is crucial for early detection in high-risk individuals and is currently recommended to improve outcomes. Tune in to this expert-led, on-demand video for a discussion on the latest recommendations, guidelines, and best practices related to lung cancer scree....

Enhancing Midwifery Practice for Improved Preeclampsia Outcomes in Low-Resource Settings

Dr. Isabella Garti
  • Duration: 1h

  • Ref. 201447

Preeclampsia remains one of the leading causes of maternal and perinatal mortality, especially in low-resource settings. We will explore the evolving evidence and best practices in the prevention, early detection, and management of hypertensive disorders in pregnancy, focusing on the midwife’s central role. The session highligh....

Assessing the Articulatory System

Stephen Davies and Ziad Al-Ani
  • Duration: 30m

  • Ref. 201399

This session describes the need for a systematic examination of the articulatory system and how to perform this examination. It also discusses how to decide on an appropriate method that will allow the results to be recorded in the clinical records.

The Limitations of Dental Health Education

Blánaid Daly
  • Duration: 30m

  • Ref. 201410

This session discusses dental health education, and focuses on the role of the dentist in practice. It explores the relationship between health education and health promotion in outlining the key dental health messages for individuals.

Successful Radiographic Techniques

Fiona Carmichael
  • Duration: 30m

  • Ref. 201409

Effective dental radiography assists the dentist in effective patient case management. The dentist should be aware of the techniques that produce consistently good results and be able to identify when that top standard is not reached.

Decontamination

Chris Dickinson
  • Duration: 30m

  • Ref. 201413

This session will provide an overview of disinfection, sterilisation and decontamination relevant to dental instruments and equipment. It will discuss the methods used to reprocess instruments and equipment used in clinical dental treatment.

Intravenous Cannulation

Kathy Wilson
  • Duration: 30m

  • Ref. 201404

This session will describe the principles of intravenous cannulation for conscious sedation in dentistry, including the equipment required, the cannulation technique and complications which may arise.

Managing Risk

Laura Gartshore
  • Duration: 30m

  • Ref. 201415

Risk management is a key aspect of clinical governance and involves having robust systems in place to understand, monitor and minimise risks to patients and staff and to learn from mistakes.

Professional guidelines for dental general anaesthesia

Kathy Wilson
  • Duration: 30m

  • Ref. 201398

This session will outline the UK national guidelines relating to the provision of general anaesthesia for dental treatment.